FDA announces new procedures to speed drug availability for life-threatening and severely debilitating conditions.
D002388:Catastrophic Illness; D004341:Drug Evaluation / Q000379:methods*; D004345:Drug Industry; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration